Clinical Trials Browser

Phase 4 × Thalidomide × 90 days × Clear all

NCT02844309 2026-02-11

BDH-WM02

Phase 4 Completed

Waldenstrom Macroglobulinemia

NCT02858804 2026-02-11

BDH-MCL01

Phase 4 Completed

Lymphoma, Mantle-Cell